MacroGenics Inc. (MGNX)
NASDAQ: MGNX
· Real-Time Price · USD
1.50
-0.01 (-0.66%)
At close: Jun 04, 2025, 3:59 PM
1.54
3.01%
After-hours: Jun 04, 2025, 04:43 PM EDT
MacroGenics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Contract Manufacturing Revenue | 13.06M | 9.83M | 13.99M | 12.35M | 97.76M | 62.02M |
| Contract Manufacturing Revenue Growth | +32.79% | -29.70% | +13.27% | -87.37% | +57.62% | n/a |
| Product Revenue | 16.43M | 17.94M | 16.73M | 63.29M | 7.12M | 2.16M |
| Product Revenue Growth | -8.43% | +7.25% | -73.57% | +789.09% | +228.97% | n/a |
| Revenue From Collaborative Agreements Revenue | 118.86M | 28.99M | 119.3M | 1.8M | n/a | n/a |
| Revenue From Collaborative Agreements Revenue Growth | +309.99% | -75.70% | +6513.25% | n/a | n/a | n/a |
| Revenue From Government Agreements Revenue | 1.62M | 1.56M | 1.92M | n/a | n/a | n/a |
| Revenue From Government Agreements Revenue Growth | +4.31% | -19.08% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.72M | 27.81M | 14.1M | 14.42M | 14.71M | 12.56M | 12.41M | 13.69M | 13.53M | 13.67M | 15.36M | 13.67M | 16.25M | 15.58M | 17.16M | 15.23M | 15.04M | 12.56M | 9.73M | 10.22M | 10.23M | 11.89M | 11.83M | 12.12M | 10.22M | 10.55M | 9.58M | 11.13M | 9.23M | 8.4M | 8.4M | 8.38M | 7.46M | 9.23M | 7.22M | 7.24M | 6.13M | 6.71M | 6.02M | 5.35M | 4.68M |
| Selling, General, and Administrative Revenue Growth | -61.46% | +97.18% | -2.21% | -1.94% | +17.11% | +1.22% | -9.37% | +1.22% | -1.06% | -10.96% | +12.33% | -15.90% | +4.30% | -9.20% | +12.65% | +1.32% | +19.70% | +29.07% | -4.74% | -0.17% | -13.94% | +0.48% | -2.38% | +18.62% | -3.11% | +10.05% | -13.92% | +20.56% | +9.89% | +0.01% | +0.23% | +12.36% | -19.20% | +27.84% | -0.21% | +18.03% | -8.67% | +11.53% | +12.63% | +14.16% | n/a |
| Research and Development Revenue | 39.7M | 38.89M | 40.54M | 51.73M | 46.03M | 45.45M | 30.13M | 43.23M | 45.87M | 45.65M | 48.19M | 51.74M | 61.44M | 55.85M | 49.82M | 55.78M | 53.12M | 42.3M | 44.66M | 57.35M | 48.89M | 51.96M | 44.85M | 51.44M | 47.06M | 46.92M | 46.22M | 52.01M | 45.67M | 38.99M | 40.98M | 34.46M | 32.8M | 31.11M | 30.3M | 33.34M | 27.35M | 30.04M | 24.1M | 22.66M | 21.46M |
| Research and Development Revenue Growth | +2.08% | -4.08% | -21.63% | +12.39% | +1.27% | +50.84% | -30.30% | -5.76% | +0.48% | -5.27% | -6.87% | -15.78% | +10.00% | +12.10% | -10.68% | +5.01% | +25.58% | -5.28% | -22.14% | +17.30% | -5.90% | +15.84% | -12.81% | +9.31% | +0.29% | +1.53% | -11.14% | +13.89% | +17.14% | -4.88% | +18.93% | +5.06% | +5.44% | +2.68% | -9.13% | +21.92% | -8.98% | +24.65% | +6.37% | +5.57% | n/a |